FDA requests information to explore whether current gluten labeling rules adequately protect consumers, with implications for ...
The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation and behavior from their labels following an investigation, the agency stated ...
As the FDA moves to finalize a rule requiring front-of-package (FOP) nutrition labels on most packaged foods and beverages in ...
The agency issued a request for more information that will shape new regulation on ingredient transparency.
The U.S. Food and Drug Administration (FDA) is taking active steps to improve disclosure of gluten ingredients in foods.
Results from the iDose TR exchange trial showed a second administration and removal of the original implant was safe and well tolerated over 12 months.
The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices. Large ...
The FDA has issued a critical recall of Gregory’s Foods cookies due to an undeclared ingredient that poses a severe risk to ...
On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results